Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-009738
Filing Date
2025-07-29
Accepted
2025-07-29 16:16:01
Documents
77
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20250630x10q.htm   iXBRL 10-Q 2489523
2 EX-10.8 knsa-20250630xex10d8.htm EX-10.8 65606
3 EX-10.9 knsa-20250630xex10d9.htm EX-10.9 202724
4 EX-31.1 knsa-20250630xex31d1.htm EX-31.1 11241
5 EX-31.2 knsa-20250630xex31d2.htm EX-31.2 10397
6 EX-32.1 knsa-20250630xex32d1.htm EX-32.1 6203
7 EX-32.2 knsa-20250630xex32d2.htm EX-32.2 6177
  Complete submission text file 0001558370-25-009738.txt   9978502

Data Files

Seq Description Document Type Size
8 EX-101.SCH knsa-20250630.xsd EX-101.SCH 56485
9 EX-101.CAL knsa-20250630_cal.xml EX-101.CAL 52718
10 EX-101.DEF knsa-20250630_def.xml EX-101.DEF 293110
11 EX-101.LAB knsa-20250630_lab.xml EX-101.LAB 484236
12 EX-101.PRE knsa-20250630_pre.xml EX-101.PRE 402494
80 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20250630x10q_htm.xml XML 1790796
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 251162074
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)